References
[1]. El-Ghariani K, Unsworth DJ. Therapeutic
apheresis–plasmapheresis. Clin Med (Lond) 2006; 6 (4): 343-7. doi:
10.7861/clinmedicine.6-4-343
[2]. Vatazin AV, Zulkarnaev AB. The impact of therapeutic plasma
exchange and double filtration plasmapheresis on hemostasis in renal
transplant recipients. Ter Arkh 2018; 90 (6): 22-27. doi:
10.26442/terarkh201890622-27
[3]. Daga Ruiz D, Fonseca San Miguel F, González de Molina FJ, et
al. Plasmapheresis and other extracorporeal filtration techniques in
critical patients. Med Intensiva 2017; 41 (3): 174-187. doi:
10.1016/j.medin.2016.10.005
[4]. Kintzel PE, Eastlund T, Calis KA. Extracorporeal removal of
antimicrobials during plasmapheresis. J Clin Apher 2003; 18 (4):
194-205. doi: 10.1002/jca.10074
[5]. Ibrahim RB, Balogun RA. Medications and therapeutic apheresis
procedures: are we doing our best? J Clin Apher 2013; 28 (1): 73-7. doi:
10.1002/jca.21261
[6]. Cheng CW, Hendrickson JE, Tormey CA, et al. Therapeutic Plasma
Exchange and Its Impact on Drug Levels: An ACLPS Critical Review. Am J
Clin Pathol. 2017; 148 (3): 190-198. doi: 10.1093/ajcp/aqx056
[7]. Mahmoud SH, Buhler J, Chu E, et al. Drug Dosing in Patients
Undergoing Therapeutic Plasma Exchange. Neurocrit Care 2021; 34 (1):
301-311. doi: 10.1007/s12028-020-00989-1
[8]. Lew SQ. Amphotericin B removal by plasma exchange. J Clin Pharm
Ther 2009; 34 (1): 115-7. doi: 10.1111/j.1365-2710.2008.00964.x
[9]. Krzych ŁJ, Czok M, Putowski Z. Is Antimicrobial Treatment
Effective During Therapeutic Plasma Exchange? Investigating the Role of
Possible Interactions. Pharmaceutics 2020; 12 (5): 395. doi:
10.3390/pharmaceutics12050395
[10]. Ibrahim RB, Balogun RA. Medications in patients treated with
therapeutic plasma exchange: prescription dosage, timing, and drug
overdose. Semin Dial 2012; 25 (2): 176-89. doi:
10.1111/j.1525-139X.2011.01030.x
[11]. Azoulay E, Bauer PR, Mariotte E, et al. Expert statement on
the ICU management of patients with thrombotic thrombocytopenic purpura.
Intensive Care Med 2019; 45 (11): 1518-1539. doi:
10.1007/s00134-019-05736-5
[12]. Fauvelle F, Petitjean O, Tod M, et al. Clinical
pharmacokinetics during plasma exchange. Therapie 2000; 55 (2): 269-75
[13]. McClellan SD, Whitaker CH, Friedberg RC. Removal of vancomycin
during plasmapheresis. Ann Pharmacother 1997; 31 (10): 1132-6. doi:
10.1177/106002809703101003
[14]. Kale-Pradhan PB, Dehoorne-Smith ML, Jaworski DA, et al.
Evaluation of plasmapheresis on the removal of tobramycin.
Pharmacotherapy 1995; 15 (5): 673-6. doi:
10.1002/j.1875-9114.1995.tb02879.x
[15]. Dong X, He M, Song X, et al. Performance and comparison of the
Cockcroft-Gault and simplified Modification of Diet in Renal Disease
formulae in estimating glomerular filtration rate in a Chinese Type 2
diabetic population. Diabet Med 2007; 24 (12): 1482-6. doi:
10.1111/j.1464-5491.2007.02275.x
[16]. Ibrahim RB, Liu C, Cronin SM, et al. Drug removal by
plasmapheresis: an evidence-based review. Pharmacotherapy 2007; 27:
1529–1549. doi: 10.1592/phco.27.11.1529
[17]. Shelat SG. Practical considerations for planning a therapeutic
apheresis procedure. Am J Med 2010; 123 (9): 777–84. doi:
10.1016/j.amjmed.2010.01.022
[18]. Charlton M, Thompson JP. Pharmacokinetics in sepsis. BJA Educ
2019; 19 (1): 7-13. doi: 10.1016/j.bjae.2018.09.006.
[19]. Ulldemolins M, Roberts JA, Rello J, et al. The effects of
hypoalbuminaemia on optimizing antibacterial dosing in critically ill
patients. Clin Pharmacokinet 2011; 50 (2): 99-110. doi:
10.2165/11539220-000000000-00000
[20]. Ghannoum M, Roberts DM,
Hoffman RS, et al. A stepwise approach for the management of poisoning
with extracorporeal treatments. Semin Dial 2014; 27 (4): 362-70. doi:
10.1111/sdi.12228